Appendix 4C Quarterly report for entities admitted on the basis of commitments

Introduced 31/3/2000. Amended 30/9/2001, 24/10/2005.

Name of entity

J Medical Australia Limited

182.00 Rule 4.7B

1:#N 30 096 048 912

Consolidated statement of cash flows

Quarter ended ("current quarter")

I 3otl, June 2016

Current quarter Year to date Cash flows related to operating activities $A'ooo (12 months)

$A'ooo

1.1 Receipts from customers 3,215 14,074

1.2 Payments for (a) staff costs (603) (3,439)

  1. advertising and marketing - -

  2. research and development - -

  3. leased assets (4) (34)

(e) inventory (1,812) (6,120)

(f) other working capital (683)(4,437)

1.3 Dividends received - -

  1. Interest and other items of a similar nature

    received --

  2. Interest and other costs of finance paid - -

1.6 Income taxes refund (R&D tax refund) 23 49

1.7 Other (provide details if material) - -

Net operating cash flows 136 93

+ See chapter 19 for defined terms.

Appendix 4C Page 1

Current quarter

$A'ooo

Year to date (12 months)

$A'ooo

1.8 Net operating cash flows (carried forward)

136

93

Cash flows related to investing activities

(45)

(398)

Payment for acquisition of:

(a) businesses (item 5)

(b) equity investments

(c) intellectual property

(d) physical non-current assets

(e) other non-current assets

1.10 Proceeds from disposal of:

(a) businesses (item s)

39

(b) equity investments

(c) intellectual property

135

135

(d) physical non-current assets

(e) other non-current assets

1.11 Loans to other entities

1.12 Loans repaid by other entities

46

46

1.13 Other (cash balance for acquired business)

Net investing cash flows

136

(178)

1.14 Total operating and investing cash flows

272

(85)

Cash flows related to financing

activities

1.15 Proceeds from issues of shares, options, etc.

1.16 Proceeds from sale o_f forfeited shares

1.17 Proceeds from borrowings

1.18 Repayment of borrowings

1.19 Dividends paid

1.20 Other (provide details if material)

Net financing cash flows

Net increase I (decrease) in cash held

272

(85)

1.21 Cash at beginning of quarter/year to date

608

982

1.22 Exchange rate adjustments

(1)

(18)

1.2 Cash at end of Quarter

879

879

+ See chapter 19 for defined terms. Appendix 4C Page 2

Payments to directors of the entity and associates of the directors Payments to related entities of the entity and associates of the related entities

Current quarter

$A'ooo

1.24 Aggregate amount of payments to the parties included in item 1.2 48

1.25 Aggregate amount of loans to the parties included in item 1.11 -

1.26 Explanation necessary for an understanding of the transactions ($A'ooo)

Directors Fees

Professional Fees (Company Secretarial)

37

11

48

Non-cash financing and investing activities

2.1 Details of financing and investing transactions which have had a material effect on

consolidated assets and liabilities but did not involve cash flows

NIA

2.2 Details of outlays made by other entities to establish or increase their share in businesses in which the reporting entity has an interest

I N/A

Financing facilities available

Add notes as necessaryfor an understanding of the position. (See AASB 1026 paragra ph 12.2).

Amount available

$A'ooo

Amount used

$A'ooo

-

-

-

-

-

-

  1. Loan facilities

  2. Credit standby arrangements

  3. Bank Overdraft

+ See chapter 19 for defined terms.

Appendix 4C Page 3

Reconciliation of cash

Reconciliation of cash at the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts is as follows.

Current quarter

$.A'ooo

Previous quarter

$A'ooo

  1. Cash on hand and at bank

  2. Term deposits

  3. Bank overdraft

  4. Other (restricted cash)

829

558

-

-

-

-

50

50

Total: cash at end of quarter (item 1.23)

879

608

Acquisitions and disposals of business entities

Acquisitions $.A'ooo

(Item 1.q(a))

Disposals $.A'ooo

(Item 1.10(a))

5.1 Name of entity

Place of

2 incorporation or registration Consideration (net of

5·3 cash in entity) for

disposal

5·4 Total net assets

5·5 Nature of business

Compliance statement

1 This statement has been prepared under accounting policies which comply with accounting standards as defined in the Corporations Act (except to the extent that information is not required because of note 2) or other standards acceptable to ASX.

2 ./This s/ta_J;errr does give a tr,u:e -an.d·_f:ai1!-view-0f:the.

Sr ···" " ............................................................. Date: 28 July 2016

·· ···· (Director/Company secretary)

Print name: Ian Mitchell

Notes

+ See chapter 19 for defined terms. Appendix 4C Page 4

Medical Australia Limited published this content on 29 July 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 28 July 2016 23:06:03 UTC.

Original documenthttp://www.medaust.com/irm/PDF/1511/Appendix4Cquarterly

Public permalinkhttp://www.publicnow.com/view/871EB36EAF319AA25D4D2609BFD222D1528F0735